Table 5.
Rates of clinical depression over time in relation to liver disease progression*
| Study Visit | No Liver Disease progression | Yes Liver Disease progression | ||
|---|---|---|---|---|
| N | Number depressed (%) | N | Number depressed (%) | |
| Baseline | 85 | 21 (24.7) | 36 | 10 (27.8) | 
| 12 month | 83 | 20 (24.1) | 36 | 14 (38.9) | 
| 24 month | 80 | 19 (23.8) | 33 | 11 (33.3) | 
| 36 month | 77 | 22 (28.6) | 30 | 12 (40.0) | 
| 48 month | 70 | 17 (24.3) | 26 | 10 (38.5) | 
After controlling for baseline clinical depression rates (p<0.001), the percentage of people with clinical depression was significantly higher among patients with liver disease progression (p=0.016) compared to those without progression in their liver disease using ANOVA modeling. The proportions did not change over time (p=0.82), nor was there an interaction between time and liver disease progression (p=0.98).